Organ-Specific Requirements for Cell Adhesion Molecules During Lymphoma Cell Dissemination

  • D. Naor
  • R. Vogt Sionov
  • M. Zahalka
  • M. Rochman
  • B. Holzmann
  • D. Ish-Shalom
Part of the Current Topics in Microbiology and Immunology book series (CT MICROBIOLOGY, volume 231)

Abstract

The malignant process is, in many aspects, a distorted image of normal physiological activities. In this respect, the dissemination mechanism of malignant lymphomas may display a hazy reflection of normal cell migration, an essential function of the lymphoid system. The successful response of the individual’s defense machinery against invading microorganisms is largely due to its ability to rapidly mobilize leukocytes to the site of infection. Cell motility in blood, lymph, lymphoid organs and tissues is highly dependent on the coordinated activity of different cell adhesion molecules. These are implicated in the transendothelial migration of intravasated and extravasated cells, the capture of cells by the luminal surface of the endothelium, cell rolling and cell arrest in the vasculature, binding of lymphocytes to the high endothelial venule (HEV) of the lymph node, as well as subsequent cell lodgment in organ parenchyma (a process known as cell homing), and cell migration on extracellular matrix (ECM) (Parkhurst and Saltzman 1992; Picker and Butcher 1992; Thomas et al. 1992; Springer 1994; Ley and Tedder 1995). Three pairs of adhesion receptor and counterreceptor families are implicated in the interaction between leukocytes and their target cells in the endothelium and tissues: (1) integrins, which target molecules of the immunoglobulin superfamily (IgSF) or ECM components, (2) selectins, which interact with sialylated carbohydrate determinants O-linked to mucin-like molecules (also known as addressins), and (3) CD44 receptors with binding affinity for matrix and cell surface constituents (Ruoslahti 1991; Yamada 1991; Picker and Butcher 1992; Lesley et al. 1993; Springer 1994; Naor et al. 1997).

Keywords

Migration Heparin Oncol Lysine Arginine 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Albelda SM, Mette SA, Elder DE, Stewart RM, Damjanovich L, Herlyn M, Buck CA (1990) Integrin distribution in malignant melanoma: association of the p3 subunit with tumor progression. Cancer Res 50: 6757–6764PubMedGoogle Scholar
  2. Arch R, Wirth K, Hofmann M, Ponta H, Matzku S, Herrlich P, Zoller M (1992) Participation in normal immune responses of a metastasis-inducing splice variant of CD44. Science 257: 682–685PubMedCrossRefGoogle Scholar
  3. Bartolazzi A, Peach R, Aruffo A, Stamenkovic I (1994) Interaction between CD44 and hyaluronate is directly implicated in the regulation of tumor development. J Exp Med 180: 53–66PubMedCrossRefGoogle Scholar
  4. Bartolazzi A, Jackson D, Bennett K, Aruffo A, Dickinson R, Shields J, Whittle N, Stamenkovic I (1995) Regulation of growth and dissemination of a human lymphoma by CD44 splice variants. J Cell Sci 108: 1723–1733PubMedGoogle Scholar
  5. Bourguignon LYW, Lokeshwar VB, Chen X, Kerrick WGL (1993) Hyaluronic acid-induced lymphocyte signal transduction and HA receptor (GP85/CD44)-cytoskeleton interaction. J Immunol 151: 6634–6644PubMedGoogle Scholar
  6. Butcher EC (1991) Leukocyte-endothelial cell recognition: three (or more) steps to specificity and diversity. Cell 67: 1033–1036PubMedCrossRefGoogle Scholar
  7. Butcher EC, Scollay RG, Weissman IL (1979) Lymphocyte adherence to high endothelial venules: characterization of a modified in vitro assay, and examination of the binding of syngeneic and allogeneic lymphocyte populations. J Immunol 123: 1996–2003PubMedGoogle Scholar
  8. Chan BMC, Matsuura N, Takada Y, Zetter BR, Hemler ME (1991) In vitro and in vivo consequences of VLA-2 expression on rhabdomyosarcoma cells. Science 251: 1600–1602PubMedCrossRefGoogle Scholar
  9. Clayberger C, Medeiros LJ, Link MP, Warnke RA, Wright A, Koller TD, Smith SD, Krensky AM (1987) Absence of cell surface LFA-1 as a mechanism of escape from immunosurveillance. Lancet 2: 533–536PubMedCrossRefGoogle Scholar
  10. Culty M, Miyake K, Kincade PW, Silorski E, Butcher EC, Underhill C (1990) The hyaluronate receptor is a member of the CD44 (H-CAM) family of cell surface glycoproteins. J Cell Biol 111: 2765–2774PubMedCrossRefGoogle Scholar
  11. Damle NK, Klussman K, Leytze G, Aruffo A, Linsley PS, Ledbetter J A (1993) Costimulation with integrin ligands intercellular adhesion molecule-1 or vascular cell adhesion molecule-1 augments activation-induced death of antigen-specific CD4+ T lymphocytes. J Immunol 151: 2368–2379PubMedGoogle Scholar
  12. Driessens MHE, Stroeken PJM, Rodriguez Erena NF, van der Valk MA, van Rijthoven EAM, Roos E (1995) Targeted disruption of CD44 in MDAY-D2 lymphosarcoma cells has no effect on subcutaneous growth or metastatic capacity. J Cell Biol 131: 1849–1855PubMedCrossRefGoogle Scholar
  13. Dustin ML, Springer TA (1991) Role of lymphocyte adhesion receptors in transient interactions and cell locomotion. Annu Rev Immunol 9: 27–66PubMedCrossRefGoogle Scholar
  14. Eisenbach L, Feldman M (1991) Tumor cell surface determinants in host immunity against metastases. Cancer Biol 2: 179–188Google Scholar
  15. Feldman M, Eisenbach L (1991) MHC class I genes controlling the metastatic phenotype of tumor cells. Cancer Biol 2: 337–346Google Scholar
  16. Funaro A, Spagnoli GC, Momo M, Knapp W, Malavasi F (1994) Stimulation of T cells via CD44 requires leukocyte-function-associated antigen interactions and interleukin-2 production. Hum Immunol 40: 267–278PubMedCrossRefGoogle Scholar
  17. Gallatin WM, Weissman IL, Butcher EC (1983) A cell-surface molecule involved in organ-specific homing of lymphocytes. Nature 304: 30–34PubMedCrossRefGoogle Scholar
  18. Galluzzo E, Albi N, Fiorucci S, Merigiola C, Ruggeri L, Tosti A, Grossi CE, Velardi A (1995) Involvement of CD44 variant isoforms in hyaluronate adhesion by human activated T cells. Eur J Immunol 25: 2932–2939PubMedCrossRefGoogle Scholar
  19. Giancotti FG, Ruoslahti E (1990) Elevated levels of the a5pi fibronectin receptor suppress the transformed phenotype of Chinese hamster ovary cells. Cell 60: 849–859PubMedCrossRefGoogle Scholar
  20. Gosslar U, Jonas P, Luz A, Lifka A, Naor D, Hamann A, Holzmann B (1996) Predominant role of a4-integrins for distinct steps of lymphoma metastasis. Proc Natl Acad Sci USA 93: 4821–4826PubMedCrossRefGoogle Scholar
  21. Giinthert U, Hofmann M, Rudy W, Reber S, Zoller M, HauBmann I, Matzku S, Wenzel A, Ponta H, Herrlich P (1991) A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 65: 13–24CrossRefGoogle Scholar
  22. Guo Y, Ma J, Wang J, Che X, Narula J, Bigby M, Wu M, Sy M-S (1994) Inhibition of human melanoma growth and metastasis in vivo by anti-CD44 monoclonal antibody. Cancer Res 54: 1561–1565PubMedGoogle Scholar
  23. Hamann A, Andrew DP, Jablonski-Westrich D, Holzmann B, Butcher EC (1994) Role of a4-integrins in lymphocyte homing to mucosal tissues in vivo. J Immunol 152: 3282–3293PubMedGoogle Scholar
  24. Hardingham TE, Fosang AJ (1992) Proteoglycans: many forms and many functions. FASEB J 6: 861–870PubMedGoogle Scholar
  25. Harning R, Myers C, Merluzzi VJ (1993) Monoclonal antibodies to lymphocyte function-associated antigen-1 inhibit invasion of human lymphoma and metastasis of murine lymphoma. Clin Exp Metastasis 11: 337–342PubMedCrossRefGoogle Scholar
  26. Hu MC-T, Crowe DT, Weissman IL, Holzmann B (1992) Cloning and expression of mouse integrin (3P (P7): A functional role in Peyer’s patch-specific lymphocyte homing. Proc Natl Acad Sci USA 89: 8254–8258Google Scholar
  27. Huang Y-W, Richardson J A, Vitetta ES (1995) Anti-CD54 (ICAM-1) has antitumor activity in SCID mice with human myeloma cells. Cancer Res 55: 610–616PubMedGoogle Scholar
  28. Jalkanen S, Bargatze RF, de los Toyos J, Butcher EC (1987) Lymphocyte recognition of high endothelium: antibodies to distinct epitopes of an 85-95-kD glycoprotein antigen differentially inhibit lymphocyte binding to lymph node, mucosal, or synovial endothelial cells. J Cell Biol 105: 983–990PubMedGoogle Scholar
  29. Johnston SC, Dustin ML, Hibbs ML, Springer TA (1990) On the species specificity of the interaction of LFA-1 with intercellular adhesion molecules. J Immunol 145: 1181–1187PubMedGoogle Scholar
  30. Katoh S, Zheng Z, Oritani K, Shimozato T, Kincade PW (1995) Glycosylation of CD44 negatively regulates its recognition of hyaluronan. J Exp Med 182: 419–429PubMedCrossRefGoogle Scholar
  31. Koopman G, van Kooyk Y, de Graaff M, Meyer CJLM, Figdor CG, Pals ST (1990) Triggering of the CD44 antigen on T lymphocytes promotes T cell adhesion through the LFA-1 pathway. J Immunol 145: 3589–3593Google Scholar
  32. Koopman G, Heider K-H, Horst E, Adolf GR, van den Berg F, Ponta H, Herrlich P, Pals ST (1993) Activated human lymphocytes and aggressive non-Hodgkin’s lymphoma express a homologue of the rat metastasis-associated variant of CD44. J Exp Med 177: 897–904PubMedCrossRefGoogle Scholar
  33. Laurent TC, Fraser JRE (1992) Hyaluronan. FASEB J 6: 2397–2404PubMedGoogle Scholar
  34. Lesley J, Hyman R, Kincade PW (1993) CD44 and its interaction with extracellular matrix. Adv Immunol 54: 271–335PubMedCrossRefGoogle Scholar
  35. Lesley J, English N, Perschl A, Gregoroff J, Hyman R (1995) Variant cell lines selected for alterations in the function of the hyaluronan receptor CD44 show differences in glycosylation. J Exp Med 182: 431–437PubMedCrossRefGoogle Scholar
  36. Ley K, Tedder TF (1995) Leukocyte interactions with vascular endothelium. New insights into selectin mediated attachment and rolling. J Immunol 155: 525–528Google Scholar
  37. Liao H-X, Levesque MC, Patton K, Bergamo B, Jones D, Moody MA, Telen MJ, Haynes BF (1993) Regulation of human CD44H and CD44E isoform binding to hyaluronan by phorbol myristate acetate and anti-CD44 monoclonal and polyclonal antibodies. J Immunol 151: 6490–6499PubMedGoogle Scholar
  38. Lokeshwar VB, Fregien N, Bourguignon LYW (1994) Ankyrin-binding domain of CD44 (GP85) is required for the expression of hyaluronic acid-mediated adhesion function. J Cell Biol 126: 1099–1109PubMedCrossRefGoogle Scholar
  39. Lugasi H, Hajos S, Murphy JR, Strom TB, Nichols J, Penarroja C, Naor D (1990) Murine spontaneous T-cell leukemia constitutively expressing IL-2 receptor-A model for human T-cell malignancies expressing IL-2 receptor. Int J Cancer 45: 163–167PubMedCrossRefGoogle Scholar
  40. Mackay CR (1992) Migration pathways and immunologic memory among T lymphocytes. Semin Immunol 4: 51–58PubMedGoogle Scholar
  41. Mackay CR, Marston WL, Dudler L (1990) Naive and memory T cells show distinct pathways of lymphocyte recirculation. J Exp Med 171: 801–817PubMedCrossRefGoogle Scholar
  42. Matsumura Y, Sugiyama M, Matsumura S, Hayle AJ, Robinson P, Smith JC, Tarin D (1995) Unusual retention of introns in CD44 gene transcripts in bladder cancer provides new diagnostic and clinical oncological opportunities. J Pathol 177: 11–20PubMedCrossRefGoogle Scholar
  43. Murakami S, Shimabukuro Y, Miki Y, Saho T, Hino E, Kasai D, Nozaki T, Kusumoto Y, Okada H (1994) Inducible binding of human lymphocytes to hyaluronate via CD44 does not require cytoskeleton association but does require new protein synthesis. J Immunol 152: 467–477PubMedGoogle Scholar
  44. Naor D, Vogt Sionov R, Ish-Shalom D (1997) CD44: structure, function and association with the malignant process. Adv Cancer Res 71: 241–319PubMedCrossRefGoogle Scholar
  45. Pals ST, Hogervorst F, Keizer GD, Thepen T, Horst E, Figdor CC (1989) Identification of a widely distributed 90-kDa glycoprotein that is homologous to the Hermes-1 human lymphocyte homing receptor. J Immunol 143: 851–857PubMedGoogle Scholar
  46. Parkhurst MR, Saltzman WM (1992) Quantification of human neutrophil motility in three-dimensional collagen gels. Effect of collagen concentration. Biophys J 61: 306–315PubMedCrossRefGoogle Scholar
  47. Patel DD, Hale LP, Whichard LP, Radcliff G, Mackay CR, Haynes BF (1995) Expression of CD44 molecules and CD44 ligands during human thymic fetal development: expression of CD44 isoforms is developmentally regulated. Int Immunol 7: 277–286PubMedCrossRefGoogle Scholar
  48. Peach RJ, Hollenbaugh D, Stamenkovic I, Aruffo A (1993) Identification of hyaluronic acid binding sites in the extracellular domain of CD44. J Cell Biol 122: 257–264PubMedCrossRefGoogle Scholar
  49. Perschl A, Lesley J, English N, Trowbridge I, Hyman R (1995) Role of CD44 cytoplasmic domain in hyaluronan binding. Eur J Immunol 25: 495–501PubMedCrossRefGoogle Scholar
  50. Picker LJ, Butcher EC (1992) Physiological and molecular mechanisms of lymphocyte homing. Annu Rev Immunol 10: 561–591PubMedCrossRefGoogle Scholar
  51. Pillemer G, Lugasi-Evgi H, Scharovsky G, Naor D (1992) Insulin dependence of murine lymphoid T-cell leukemia. Int J Cancer 50: 80–85PubMedCrossRefGoogle Scholar
  52. Qian F, Vaux DL, Weissman IL (1994) Expression of the integrin oc4pi on melanoma cells can inhibit the invasive stage of metastasis formation. Cell 77: 335–347PubMedCrossRefGoogle Scholar
  53. Rincon J, Prieto J, Patarroyo M (1992) Expression of integrins and other adhesion molecules in Epstein-Barr virus-transformed B lymphoblastoid cells and Burkitt’s lymphoma cells. Int J Cancer 51: 452–458PubMedCrossRefGoogle Scholar
  54. Ristamaki R, Joensuu H, Soderstrom K-O, Jalkanen S (1995) CD44v6 expression in non-Hodgkin’s lymphoma: an association with low histological grade and poor prognosis. J Pathol 176: 259–267PubMedCrossRefGoogle Scholar
  55. Rocha M, Kriiger A, Umansky V, von Hoegen P, Naor D, Schirrmacher V (1996) Dynamic expression changes in vivo of adhesion and costimulatory molecules determine load and pattern of lymphoma liver metastasis. Clin Cancer Res 2: 811–820PubMedGoogle Scholar
  56. Rodrigues M, Nussenzweig RS, Romero P, Zavala F (1992) The in vivo cytotoxic activity of CD8+ T cell clones correlates with their levels of expression of adhesion molecules. J Exp Med 175: 895–905PubMedCrossRefGoogle Scholar
  57. Rudy W, Hofmann M, Schwartz-Albiez R, Zoller M, Heider K-H, Ponta H, Heniich P (1993) The two major CD44 proteins expressed on a metastatic rat tumor cell line are derived from different splice variants: each one individually suffices to confer metastatic behavior. Cancer Res 53: 1262–1268PubMedGoogle Scholar
  58. Ruggiero RA, Bustuoabad OD, Bonfil RD, Meiss RP, Pasqualini CD (1985) “Concomitant immunity” in murine tumours of non-detectable immunogenicity. Br J Cancer 51:37–48Google Scholar
  59. Ruoslahti E (1991) Integrins. J Clin Invest 87: 1–5CrossRefGoogle Scholar
  60. Sanchez-Madrid F, Simon P, Thompson S, Springer TA (1983) Mapping of antigenic and functional epitopes on the a- and p-subunits of two related mouse glycoproteins involved in cell interactions, LFA-1 and MAC-1. J Exp Med 158: 586–602PubMedCrossRefGoogle Scholar
  61. Screaton GR, Bell MV, Jackson DG, Cornelis FB, Gerth U, Bell JI (1992) Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc Natl Acad Sci USA 89: 12160–12164PubMedCrossRefGoogle Scholar
  62. Seiter S, Arch R, Reber S, Komitowski D, Hofmann M, Ponta H, Heniich P, Matzku S, Zoller M (1993) Prevention of tumor metastasis formation by anti-variant CD44. J Exp Med 177: 443–455PubMedCrossRefGoogle Scholar
  63. Sharon R, Pillemer G, Ish-Shalom D, Kalman R, Ziv E, Berry EM, Naor D (1993) Insulin dependence of murine T-cell lymphoma. II. Insulin-deficient diabetic mice and mice fed low-energy diet develop resistance to lymphoma growth. Int J Cancer 53: 843–849Google Scholar
  64. Sleeman JP, Arming S, Moll JF, Hekele A, Rudy W, Sherman LS, Kreil G, Ponta H, Heniich P (1996) Hyaluronate-independent metastatic behavior of CD44 variant-expressing pancreatic carcinoma cells. Cancer Res 56: 3134–3141PubMedGoogle Scholar
  65. Springer TA (1994) Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76: 301–314PubMedCrossRefGoogle Scholar
  66. Stauder R, Eisterer W, Thaler J, Giinthert U (1995) CD44 variant isoformsin non-Hodgkin’s lymphoma: a new independent prognostic factor. Blood 85: 2885–2899PubMedGoogle Scholar
  67. Strauch UG, Lifka A, Goßlar U, Kilshaw PJ, Clements J, Holzmann B (1994) Distinct binding specificities of integrins a4B7 (LPAM-l), a4b1 (VLA-4), and aIELb7. Int Immunol 6: 263–275PubMedCrossRefGoogle Scholar
  68. Sugimoto K, Tsurumaki Y, Hoshi H, Kadowaki S, Le Bousse-Kerdiles MC, Smadja-Joffe F, Mori KJ (1994) Effects of anti-CD44 monoclonal antibody on adhesion of erythroid leukemic cells (ELM-I-1) to hematopoietic supportive cells (MS-5): CD44, but not hyaluronate-mediated, cell-cell adhesion. Exp Hematol 22: 488–494PubMedGoogle Scholar
  69. Sy M-S, Guo Y-J, Stamenkovic I (1991) Distinct effects of two CD44 isoforms on tumor growth in vivo. J Exp Med 174: 859–866PubMedCrossRefGoogle Scholar
  70. Terpe H-J, Koopmann R, Imhof BA, Giinthert U (1994) Expression of integrins and CD44 isoforms in non-Hodgkin’s lymphomas: CD44 variant isoforms are preferentially expressed in high-grade malignant lymphomas. J Pathol 174: 89–100PubMedCrossRefGoogle Scholar
  71. Thomas L, Byers HR, Vink J, Stamenkovic I (1992) CD44H regulates tumor cell migration on hyaluronate-coated substrate. J Cell Biol 118: 971–977PubMedCrossRefGoogle Scholar
  72. Toole BP, Biswas C, Gross J (1979) Hyaluronate and invasiveness of the rabbit V2 carcinoma. Proc Natl Acad Sci USA 76: 6299–6303PubMedCrossRefGoogle Scholar
  73. Toyama-Sorimachi N, Miyake K, Miyasaka M (1993) Activation of CD44 induces ICAM-l/LFA-1- independent, Ca2 +, Mg2 +-independent adhesion pathway in lymphocyte-endothelial cell interaction. Eur J Immunol 23: 439–446PubMedCrossRefGoogle Scholar
  74. Uff CR, Neame SJ, Isacke CM (1995) Hyaluronan binding by CD44 is regulated by a phosphorylation-independent mechanism. Eur J Immunol 25: 1883–1887PubMedCrossRefGoogle Scholar
  75. van Weering DHJ, Baas PD, Bos JL (1993) A PCR-based method for the analysis of human CD44 splice products. PCR Methods Appl 3: 100–106PubMedGoogle Scholar
  76. Vogt Sionov R, Naor D (1997) Hyaluronan-independent lodgment of CD44+ lymphoma cells in lymphoid organs. Int J Cancer 71: 462–469PubMedCrossRefGoogle Scholar
  77. Walter J, Schirrmacher V, Mosier D (1995) Induction of CD44 expression by the Epstein-Barr virus latent membrane protein LMP1 is associated with lymphoma dissemination. Int J Cancer 61: 363–369PubMedCrossRefGoogle Scholar
  78. Wielenga VJM, Heider K-H, Offerhaus GJA, Adolf GR, van den Berg FM, Ponta H, Herrlich P, Pals ST (1993) Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression. Cancer Res 53: 4754–4756PubMedGoogle Scholar
  79. Wu L, Kincade PW, Shortman K (1993) The CD44 expressed on the earliest intrathymic precursor population functions as a thymus homing molecule but does not bind to hyaluronate. Immunol Lett 38: 69–75PubMedCrossRefGoogle Scholar
  80. Yamada KM (1991) Adhesive recognition sequences. J Biol Chem 266: 12809–12812PubMedGoogle Scholar
  81. Yeatman TJ, Nicolson GL (1993) Molecular basis of tumor progression: mechanisms of organ-specific tumor metastasis. Semin Surg Oncol 9: 256–263PubMedGoogle Scholar
  82. Zahalka MA, Naor D (1994) B2-integrin dependent aggregate formation between LB T cell lymphoma and spleen cells: assessment of correlation with spleen invasiveness. Int Immunol 6: 917–924PubMedCrossRefGoogle Scholar
  83. Zahalka MA, Okon E, Naor D (1993) Blocking lymphoma invasiveness with a monoclonal antibody directed against the p-chain of the leukocyte adhesion molecule (CD 18). J Immunol 150: 4466–4477PubMedGoogle Scholar
  84. Zahalka MA, Okon E, Gosslar U, Holzmann B, Naor D (1995) Lymph node (but not spleen) invasion by murine lymphoma is both CD44- and hyaluronate-dependent. J Immunol 154: 5345–5355PubMedGoogle Scholar
  85. Zhang L, Underhill CB, Chen L (1995) Hyaluronan on the surface of tumor cells is correlated with metastatic behavior. Cancer Res 55: 428–433PubMedGoogle Scholar
  86. Zheng Z, Katoh S, He Q, Oritani K, Miyake K, Lesley J, Hyman R, Hamik A, Parkhouse RME, Farr AG, Kincade PW (1995) Monoclonal antibodies to CD44 and their influence on hyaluronan recognition. J Cell Biol 130: 485–495PubMedCrossRefGoogle Scholar
  87. Zhou DFH, Ding JF, Picker LJ, Bargatze RF, Butcher EC, Goeddel DV (1989) Molecular cloning and expression of Pgp-1. The mouse homolog of the human H-CAM ( Hermes) lymphocyte homing receptor. J Immunol 143: 3390–3395Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1998

Authors and Affiliations

  • D. Naor
    • 1
  • R. Vogt Sionov
    • 1
  • M. Zahalka
    • 1
  • M. Rochman
    • 1
  • B. Holzmann
    • 2
  • D. Ish-Shalom
    • 1
  1. 1.The Lautenberg Center for General and Tumor ImmunologyThe Hebrew-University-Hadassah Medical SchoolJerusalemIsrael
  2. 2.Institute for Medical Microbiology and HygieneTechnical UniversityMunichGermany

Personalised recommendations